PERI Perion Network | $8.88
+2.3% | 4/17/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of Perion Network (NASDAQ:PERI) on 4/17/2025 |
NFLX Netflix | $973.03
+1.2% | 4/17/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $1,126.00 -> $1,126.00 | Low | View details for Needham & Company LLC rating of Netflix (NASDAQ:NFLX) on 4/17/2025 |
TSM Taiwan Semiconductor Manufacturing | $151.86
+0.1% | 4/17/2025 | Reiterated by | Needham & Company LLC | Analyst Charles Shi | Buy -> Buy | $225.00 -> $225.00 | High | View details for Needham & Company LLC rating of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 4/17/2025 |
LYFT Lyft | $11.16
+3.0% | 4/17/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of Lyft (NASDAQ:LYFT) on 4/17/2025 |
DOCU DocuSign | $75.42
-1.3% | 4/17/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of DocuSign (NASDAQ:DOCU) on 4/17/2025 |
CYRX Cryoport | $5.55
-1.1% | 4/16/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Buy | $11.00 -> $11.00 | High | View details for Needham & Company LLC rating of Cryoport (NASDAQ:CYRX) on 4/16/2025 |
BIIB Biogen | $118.61
+2.9% | 4/16/2025 | Reiterated by | Needham & Company LLC | Analyst A. Fadia | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of Biogen (NASDAQ:BIIB) on 4/16/2025 |
GOOGL Alphabet | $151.08
-1.5% | 4/16/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $178.00 -> $178.00 | Medium | View details for Needham & Company LLC rating of Alphabet (NASDAQ:GOOGL) on 4/16/2025 |
DV DoubleVerify | $12.47
+3.3% | 4/16/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $18.00 -> $18.00 | Low | View details for Needham & Company LLC rating of DoubleVerify (NYSE:DV) on 4/16/2025 |
BSX Boston Scientific | $95.08
-0.2% | 4/16/2025 | Upgraded by | Needham & Company LLC | Analyst M. Matson | Hold -> Buy | $113.00 | Medium | View details for Needham & Company LLC rating of Boston Scientific (NYSE:BSX) on 4/16/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
APLD Applied Digital | $3.94
-3.4% | 4/15/2025 | Target Lowered by | Needham & Company LLC | Analyst John Todaro | Buy -> Buy | $11.00 -> $10.00 | High | View details for Needham & Company LLC rating of Applied Digital (NASDAQ:APLD) on 4/15/2025 |
IONS Ionis Pharmaceuticals | $28.40
+0.2% | 4/15/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Needham & Company LLC rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/15/2025 |
MGNI Magnite | $11.13
+12.4% | 4/15/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $14.00 -> $14.00 | Medium | View details for Needham & Company LLC rating of Magnite (NASDAQ:MGNI) on 4/15/2025 |
AUR Aurora Innovation | $6.11
+4.1% | 4/15/2025 | Initiated by | Needham & Company LLC | Analyst Chris Pierce | Buy | $10.00 | Low | View details for Needham & Company LLC rating of Aurora Innovation (NASDAQ:AUR) on 4/15/2025 |
NBIX Neurocrine Biosciences | $101.38
+1.3% | 4/15/2025 | Upgraded by | Needham & Company LLC | Analyst Ami Fadia | Hold -> Buy | $138.00 | Low | View details for Needham & Company LLC rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/15/2025 |
INTC Intel | $18.93
-1.6% | 4/14/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Intel (NASDAQ:INTC) on 4/14/2025 |
TAP Molson Coors Beverage | $58.72
+0.0% | 4/14/2025 | Reiterated by | Needham & Company LLC | Analyst G. Pascarelli | Buy -> Buy | $72.00 -> $72.00 | Low | View details for Needham & Company LLC rating of Molson Coors Beverage (NYSE:TAP) on 4/14/2025 |
BEEM Beam Global | $1.45
+7.4% | 4/14/2025 | Reiterated by | Needham & Company LLC | Analyst Chris Pierce | Hold -> Hold | | High | View details for Needham & Company LLC rating of Beam Global (NASDAQ:BEEM) on 4/14/2025 |
ROKU Roku | $58.46
+0.1% | 4/14/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $88.50 -> $88.50 | Medium | View details for Needham & Company LLC rating of Roku (NASDAQ:ROKU) on 4/14/2025 |
TTD Trade Desk | $50.26
+3.7% | 4/14/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $84.00 -> $84.00 | High | View details for Needham & Company LLC rating of Trade Desk (NASDAQ:TTD) on 4/14/2025 |
AAPL Apple | $196.79
+1.3% | 4/14/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $225.00 -> $225.00 | High | View details for Needham & Company LLC rating of Apple (NASDAQ:AAPL) on 4/14/2025 |
ESTA Establishment Labs | $31.45
+4.2% | 4/14/2025 | Initiated by | Needham & Company LLC | Analyst Mike Matson | Hold | | Low | View details for Needham & Company LLC rating of Establishment Labs (NASDAQ:ESTA) on 4/14/2025 |
CELC Celcuity | $10.24
+2.5% | 4/11/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $29.00 -> $29.00 | Medium | View details for Needham & Company LLC rating of Celcuity (NASDAQ:CELC) on 4/11/2025 |
HRTX Heron Therapeutics | $1.84
| 4/11/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $4.00 -> $4.00 | Medium | View details for Needham & Company LLC rating of Heron Therapeutics (NASDAQ:HRTX) on 4/11/2025 |
LUCD Lucid Diagnostics | $1.21
+11.0% | 4/11/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $3.00 -> $3.00 | High | View details for Needham & Company LLC rating of Lucid Diagnostics (NASDAQ:LUCD) on 4/11/2025 |
KMX CarMax | $64.50
+0.6% | 4/11/2025 | Target Lowered by | Needham & Company LLC | Analyst Chris Pierce | Buy -> Buy | $101.00 -> $92.00 | Medium | View details for Needham & Company LLC rating of CarMax (NYSE:KMX) on 4/11/2025 |
FICO Fair Isaac | $1,907.06
+0.4% | 4/11/2025 | Reiterated by | Needham & Company LLC | Analyst Kyle Peterson | Buy -> Buy | $2,500.00 -> $2,500.00 | Medium | View details for Needham & Company LLC rating of Fair Isaac (NYSE:FICO) on 4/11/2025 |
VLN Valens Semiconductor | $2.39
+6.5% | 4/11/2025 | Initiated by | Needham & Company LLC | Analyst Quinn Bolton | Buy | $4.00 | Low | View details for Needham & Company LLC rating of Valens Semiconductor (NYSE:VLN) on 4/11/2025 |
PRVA Privia Health Group | $23.68
-0.8% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst R. Macdonald | Buy -> Buy | $30.00 -> $30.00 | High | View details for Needham & Company LLC rating of Privia Health Group (NASDAQ:PRVA) on 4/10/2025 |
NMRA Neumora Therapeutics | $0.65
+2.7% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $5.00 -> $5.00 | Low | View details for Needham & Company LLC rating of Neumora Therapeutics (NASDAQ:NMRA) on 4/10/2025 |
THRY Thryv | $12.07
+5.3% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of Thryv (NASDAQ:THRY) on 4/10/2025 |
DCBO Docebo | $29.18
+0.1% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan MacDonald | Buy -> Buy | $42.00 -> $42.00 | Low | View details for Needham & Company LLC rating of Docebo (NASDAQ:DCBO) on 4/10/2025 |
IMRX Immuneering | $1.27
+1.6% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $12.00 -> $12.00 | Medium | View details for Needham & Company LLC rating of Immuneering (NASDAQ:IMRX) on 4/10/2025 |
AMPH Amphastar Pharmaceuticals | $23.35
+1.6% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Hold -> Hold | | High | View details for Needham & Company LLC rating of Amphastar Pharmaceuticals (NASDAQ:AMPH) on 4/10/2025 |
PSNL Personalis | $3.19
-3.0% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $7.00 -> $7.00 | Medium | View details for Needham & Company LLC rating of Personalis (NASDAQ:PSNL) on 4/10/2025 |
CDTX Cidara Therapeutics | $19.44
+1.4% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $35.00 -> $35.00 | High | View details for Needham & Company LLC rating of Cidara Therapeutics (NASDAQ:CDTX) on 4/10/2025 |
LQDA Liquidia | $13.72
+0.3% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $25.00 -> $25.00 | Low | View details for Needham & Company LLC rating of Liquidia (NASDAQ:LQDA) on 4/10/2025 |
BCRX BioCryst Pharmaceuticals | $7.40
+2.5% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $15.00 -> $15.00 | High | View details for Needham & Company LLC rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 4/10/2025 |
MASI Masimo | $152.15
+0.3% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Hold -> Hold | | High | View details for Needham & Company LLC rating of Masimo (NASDAQ:MASI) on 4/10/2025 |
IMCR Immunocore | $28.41
+1.9% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $71.00 -> $71.00 | High | View details for Needham & Company LLC rating of Immunocore (NASDAQ:IMCR) on 4/10/2025 |
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad) We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America.
Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking.
And he believes Trump could soon release this frozen asset to the public.
 But something even more spectacular is bound to happen. And those who know what to expect could make |
TEM Tempus AI | $40.42
-1.1% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan MacDonald | Buy -> Buy | $70.00 -> $70.00 | High | View details for Needham & Company LLC rating of Tempus AI (NASDAQ:TEM) on 4/10/2025 |
JAZZ Jazz Pharmaceuticals | $102.78
+1.2% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $210.00 -> $210.00 | High | View details for Needham & Company LLC rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 4/10/2025 |
AUTL Autolus Therapeutics | $1.43
+5.9% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $10.00 -> $10.00 | High | View details for Needham & Company LLC rating of Autolus Therapeutics (NASDAQ:AUTL) on 4/10/2025 |
STZ Constellation Brands | $186.58
+1.9% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst G. Pascarelli | Buy -> Buy | $215.00 -> $215.00 | High | View details for Needham & Company LLC rating of Constellation Brands (NYSE:STZ) on 4/10/2025 |
CYRX Cryoport | $5.55
-1.1% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Buy | $11.00 -> $11.00 | Low | View details for Needham & Company LLC rating of Cryoport (NASDAQ:CYRX) on 4/10/2025 |
TSHA Taysha Gene Therapies | $1.24
+5.1% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $6.00 -> $6.00 | Medium | View details for Needham & Company LLC rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/10/2025 |
GBIO Generation Bio | $0.39
+12.4% | 4/10/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $8.00 -> $8.00 | High | View details for Needham & Company LLC rating of Generation Bio (NASDAQ:GBIO) on 4/10/2025 |
INMD InMode | $14.92
+0.1% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Hold -> Hold | | High | View details for Needham & Company LLC rating of InMode (NASDAQ:INMD) on 4/9/2025 |
NRIX Nurix Therapeutics | $10.24
+4.5% | 4/9/2025 | Target Lowered by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $28.00 -> $27.00 | High | View details for Needham & Company LLC rating of Nurix Therapeutics (NASDAQ:NRIX) on 4/9/2025 |
SGHT Sight Sciences | $2.66
+1.9% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Hold -> Hold | | High | View details for Needham & Company LLC rating of Sight Sciences (NASDAQ:SGHT) on 4/9/2025 |
ENOV Enovis | $31.91
+2.4% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $64.00 -> $64.00 | High | View details for Needham & Company LLC rating of Enovis (NYSE:ENOV) on 4/9/2025 |
ZIMV ZimVie | $9.39
+1.5% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst D. Saxon | Hold -> Hold | | High | View details for Needham & Company LLC rating of ZimVie (NASDAQ:ZIMV) on 4/9/2025 |
BCYC Bicycle Therapeutics | $7.39
-1.3% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $30.00 -> $30.00 | High | View details for Needham & Company LLC rating of Bicycle Therapeutics (NASDAQ:BCYC) on 4/9/2025 |
KIDS OrthoPediatrics | $21.00
+2.0% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $42.00 -> $42.00 | High | View details for Needham & Company LLC rating of OrthoPediatrics (NASDAQ:KIDS) on 4/9/2025 |
MMSI Merit Medical Systems | $90.89
+0.4% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $116.00 -> $116.00 | High | View details for Needham & Company LLC rating of Merit Medical Systems (NASDAQ:MMSI) on 4/9/2025 |
INGN Inogen | $6.82
-0.9% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Hold -> Hold | | High | View details for Needham & Company LLC rating of Inogen (NASDAQ:INGN) on 4/9/2025 |
RCKT Rocket Pharmaceuticals | $6.33
+2.9% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $42.00 -> $42.00 | High | View details for Needham & Company LLC rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 4/9/2025 |
RNA Avidity Biosciences | $26.66
+3.5% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $60.00 -> $60.00 | High | View details for Needham & Company LLC rating of Avidity Biosciences (NASDAQ:RNA) on 4/9/2025 |
COLL Collegium Pharmaceutical | $27.01
0.0% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst S. Belanger | Buy -> Buy | $46.00 -> $46.00 | High | View details for Needham & Company LLC rating of Collegium Pharmaceutical (NASDAQ:COLL) on 4/9/2025 |
STOK Stoke Therapeutics | $7.69
+1.7% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $22.00 -> $22.00 | High | View details for Needham & Company LLC rating of Stoke Therapeutics (NASDAQ:STOK) on 4/9/2025 |
RNAC Cartesian Therapeutics | $10.50
-0.7% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $41.00 -> $41.00 | High | View details for Needham & Company LLC rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/9/2025 |
MREO Mereo BioPharma Group | $2.30
+8.0% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $7.00 -> $7.00 | High | View details for Needham & Company LLC rating of Mereo BioPharma Group (NASDAQ:MREO) on 4/9/2025 |
MRUS Merus | $43.06
+2.7% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $83.00 -> $83.00 | High | View details for Needham & Company LLC rating of Merus (NASDAQ:MRUS) on 4/9/2025 |
AVDL Avadel Pharmaceuticals | $8.03
-1.5% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $19.00 -> $19.00 | High | View details for Needham & Company LLC rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 4/9/2025 |
UBER Uber Technologies | $75.28
+3.0% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Buy -> Buy | $90.00 -> $90.00 | High | View details for Needham & Company LLC rating of Uber Technologies (NYSE:UBER) on 4/9/2025 |
TTAN ServiceTitan | $119.89
+1.9% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst S. Berg | Buy -> Buy | $125.00 -> $125.00 | High | View details for Needham & Company LLC rating of ServiceTitan (NASDAQ:TTAN) on 4/9/2025 |
CRMD CorMedix | $7.67
+2.0% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $12.00 -> $12.00 | High | View details for Needham & Company LLC rating of CorMedix (NASDAQ:CRMD) on 4/9/2025 |
ABSI Absci | $3.09
+1.3% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst G. Blum | Buy -> Buy | $9.00 -> $9.00 | High | View details for Needham & Company LLC rating of Absci (NASDAQ:ABSI) on 4/9/2025 |
EOLS Evolus | $10.79
+6.7% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $22.00 -> $22.00 | High | View details for Needham & Company LLC rating of Evolus (NASDAQ:EOLS) on 4/9/2025 |
VRCA Verrica Pharmaceuticals | $0.49
+2.4% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Hold -> Hold | | High | View details for Needham & Company LLC rating of Verrica Pharmaceuticals (NASDAQ:VRCA) on 4/9/2025 |
ARQT Arcutis Biotherapeutics | $13.01
+0.4% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $20.00 -> $20.00 | High | View details for Needham & Company LLC rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/9/2025 |
NKTX Nkarta | $1.81
+3.4% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $11.00 -> $11.00 | High | View details for Needham & Company LLC rating of Nkarta (NASDAQ:NKTX) on 4/9/2025 |
PHAT Phathom Pharmaceuticals | $4.03
-4.5% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 4/9/2025 |
CRSP CRISPR Therapeutics | $37.77
0.0% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $84.00 -> $84.00 | High | View details for Needham & Company LLC rating of CRISPR Therapeutics (NASDAQ:CRSP) on 4/9/2025 |
ALNY Alnylam Pharmaceuticals | $234.56
+1.8% | 4/9/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $320.00 -> $320.00 | High | View details for Needham & Company LLC rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 4/9/2025 |
CELH Celsius | $37.24
+1.6% | 4/9/2025 | Target Raised by | Needham & Company LLC | Analyst G. Pascarelli | Buy -> Buy | $40.00 -> $45.00 | High | View details for Needham & Company LLC rating of Celsius (NASDAQ:CELH) on 4/9/2025 |
CGNT Cognyte Software | $9.51
-2.0% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Cikos | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Cognyte Software (NASDAQ:CGNT) on 4/8/2025 |
DCGO DocGo | $2.12
-3.2% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan MacDonald | Buy -> Buy | $4.00 -> $4.00 | High | View details for Needham & Company LLC rating of DocGo (NASDAQ:DCGO) on 4/8/2025 |
HRMY Harmony Biosciences | $28.46
+1.9% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $50.00 -> $50.00 | High | View details for Needham & Company LLC rating of Harmony Biosciences (NASDAQ:HRMY) on 4/8/2025 |
PCRX Pacira BioSciences | $24.65
+0.7% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $32.00 -> $32.00 | High | View details for Needham & Company LLC rating of Pacira BioSciences (NASDAQ:PCRX) on 4/8/2025 |
ARTV Artiva Biotherapeutics | $2.24
-2.6% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $23.00 -> $23.00 | High | View details for Needham & Company LLC rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 4/8/2025 |
RXRX Recursion Pharmaceuticals | $5.50
+3.4% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $11.00 -> $11.00 | High | View details for Needham & Company LLC rating of Recursion Pharmaceuticals (NASDAQ:RXRX) on 4/8/2025 |
TCRX TScan Therapeutics | $1.44
+10.8% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $9.00 -> $9.00 | High | View details for Needham & Company LLC rating of TScan Therapeutics (NASDAQ:TCRX) on 4/8/2025 |
NAMS NewAmsterdam Pharma | $16.34
+1.9% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $42.00 -> $42.00 | High | View details for Needham & Company LLC rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 4/8/2025 |
CLSD Clearside Biomedical | $0.86
-1.1% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $4.00 -> $4.00 | High | View details for Needham & Company LLC rating of Clearside Biomedical (NASDAQ:CLSD) on 4/8/2025 |
OCX OncoCyte | $2.84
+0.4% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $4.25 -> $4.25 | High | View details for Needham & Company LLC rating of OncoCyte (NASDAQ:OCX) on 4/8/2025 |
ESPR Esperion Therapeutics | $0.95
-1.4% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $5.00 -> $5.00 | High | View details for Needham & Company LLC rating of Esperion Therapeutics (NASDAQ:ESPR) on 4/8/2025 |
CYTK Cytokinetics | $39.48
+0.8% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $72.00 -> $72.00 | High | View details for Needham & Company LLC rating of Cytokinetics (NASDAQ:CYTK) on 4/8/2025 |
RVMD Revolution Medicines | $36.76
+1.5% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $59.00 -> $59.00 | High | View details for Needham & Company LLC rating of Revolution Medicines (NASDAQ:RVMD) on 4/8/2025 |
TRVI Trevi Therapeutics | $6.07
-0.5% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $24.00 -> $24.00 | High | View details for Needham & Company LLC rating of Trevi Therapeutics (NASDAQ:TRVI) on 4/8/2025 |
The Trump Dump is starting; Get out of stocks now? (Ad) The first 365 days of the Trump presidency…
Will be the best time to get rich in American history. If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a |
INZY Inozyme Pharma | $0.92
-4.4% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $15.00 -> $15.00 | High | View details for Needham & Company LLC rating of Inozyme Pharma (NASDAQ:INZY) on 4/8/2025 |
IONS Ionis Pharmaceuticals | $28.40
+0.2% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $60.00 -> $60.00 | High | View details for Needham & Company LLC rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/8/2025 |
PCVX Vaxcyte | $30.65
+5.3% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $90.00 -> $90.00 | High | View details for Needham & Company LLC rating of Vaxcyte (NASDAQ:PCVX) on 4/8/2025 |
RYTM Rhythm Pharmaceuticals | $61.74
+0.7% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $66.00 -> $66.00 | Medium | View details for Needham & Company LLC rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 4/8/2025 |
ICUI ICU Medical | $138.67
-0.3% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Hold -> Hold | | High | View details for Needham & Company LLC rating of ICU Medical (NASDAQ:ICUI) on 4/8/2025 |
PRAX Praxis Precision Medicines | $33.79
+13.3% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $85.00 -> $85.00 | High | View details for Needham & Company LLC rating of Praxis Precision Medicines (NASDAQ:PRAX) on 4/8/2025 |
BPMC Blueprint Medicines | $84.62
+3.1% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $133.00 -> $133.00 | High | View details for Needham & Company LLC rating of Blueprint Medicines (NASDAQ:BPMC) on 4/8/2025 |
KALV KalVista Pharmaceuticals | $12.00
+2.2% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 4/8/2025 |
ACAD ACADIA Pharmaceuticals | $14.73
+1.1% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 4/8/2025 |
OCUL Ocular Therapeutix | $7.31
+2.0% | 4/8/2025 | Reiterated by | Needham & Company LLC | Analyst S. Belanger | Buy -> Buy | $15.00 -> $15.00 | High | View details for Needham & Company LLC rating of Ocular Therapeutix (NASDAQ:OCUL) on 4/8/2025 |
KRNT Kornit Digital | $18.40
-3.7% | 4/8/2025 | Target Lowered by | Needham & Company LLC | Analyst James Ricchiuti | Buy -> Buy | $34.00 -> $28.00 | High | View details for Needham & Company LLC rating of Kornit Digital (NASDAQ:KRNT) on 4/8/2025 |
STE STERIS | $222.53
+1.1% | 4/7/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Hold -> Hold | | Low | View details for Needham & Company LLC rating of STERIS (NYSE:STE) on 4/7/2025 |
IMXI International Money Express | $12.37
+3.0% | 4/7/2025 | Reiterated by | Needham & Company LLC | Analyst Mayank Tandon | Buy -> Buy | $20.00 -> $20.00 | N/A | View details for Needham & Company LLC rating of International Money Express (NASDAQ:IMXI) on 4/7/2025 |
DKNG DraftKings | $33.61
0.0% | 4/7/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Buy -> Buy | $65.00 -> $65.00 | High | View details for Needham & Company LLC rating of DraftKings (NASDAQ:DKNG) on 4/7/2025 |
DOCN DigitalOcean | $27.36
-1.8% | 4/7/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Cikos | Hold -> Hold | | High | View details for Needham & Company LLC rating of DigitalOcean (NYSE:DOCN) on 4/7/2025 |
AAPL Apple | $196.79
+1.3% | 4/4/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $260.00 -> $260.00 | High | View details for Needham & Company LLC rating of Apple (NASDAQ:AAPL) on 4/4/2025 |
THRY Thryv | $12.07
+5.3% | 4/4/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of Thryv (NASDAQ:THRY) on 4/4/2025 |
FIVN Five9 | $22.32
-1.3% | 4/4/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $52.00 -> $52.00 | High | View details for Needham & Company LLC rating of Five9 (NASDAQ:FIVN) on 4/4/2025 |
IMAB I-Mab | $0.85
+1.0% | 4/4/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $4.00 -> $4.00 | High | View details for Needham & Company LLC rating of I-Mab (NASDAQ:IMAB) on 4/4/2025 |
MEG Montrose Environmental Group | $14.55
+2.0% | 4/4/2025 | Target Lowered by | Needham & Company LLC | Analyst James Ricchiuti | Buy -> Buy | $39.00 -> $28.00 | N/A | View details for Needham & Company LLC rating of Montrose Environmental Group (NYSE:MEG) on 4/4/2025 |
ARQT Arcutis Biotherapeutics | $13.01
+0.4% | 4/3/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $20.00 -> $20.00 | Medium | View details for Needham & Company LLC rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
STGW Stagwell | $5.43
+3.2% | 4/3/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $9.00 -> $9.00 | High | View details for Needham & Company LLC rating of Stagwell (NASDAQ:STGW) on 4/3/2025 |
CURI CuriosityStream | $3.17
+8.9% | 4/3/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $3.00 -> $3.00 | High | View details for Needham & Company LLC rating of CuriosityStream (NASDAQ:CURI) on 4/3/2025 |
SRPT Sarepta Therapeutics | $53.79
-0.3% | 4/3/2025 | Target Lowered by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $202.00 -> $183.00 | High | View details for Needham & Company LLC rating of Sarepta Therapeutics (NASDAQ:SRPT) on 4/3/2025 |
YEXT Yext | $6.12
+0.6% | 4/3/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan MacDonald | Buy -> Buy | $10.00 -> $10.00 | High | View details for Needham & Company LLC rating of Yext (NYSE:YEXT) on 4/3/2025 |
PENG Penguin Solutions | $15.88
-3.4% | 4/3/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $27.00 -> $27.00 | High | View details for Needham & Company LLC rating of Penguin Solutions (NASDAQ:PENG) on 4/3/2025 |
RXST RxSight | $14.43
-0.6% | 4/3/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Buy | $43.00 -> $43.00 | High | View details for Needham & Company LLC rating of RxSight (NASDAQ:RXST) on 4/3/2025 |
CGNT Cognyte Software | $9.51
-2.0% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Cikos | Hold -> Hold | | High | View details for Needham & Company LLC rating of Cognyte Software (NASDAQ:CGNT) on 4/2/2025 |
ENOV Enovis | $31.91
+2.4% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $64.00 -> $64.00 | High | View details for Needham & Company LLC rating of Enovis (NYSE:ENOV) on 4/2/2025 |
QBTS D-Wave Quantum | $6.39
-0.9% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $8.50 -> $8.50 | Medium | View details for Needham & Company LLC rating of D-Wave Quantum (NYSE:QBTS) on 4/2/2025 |
SRAD Sportradar Group | $23.96
+0.4% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Buy -> Buy | $27.00 -> $27.00 | High | View details for Needham & Company LLC rating of Sportradar Group (NASDAQ:SRAD) on 4/2/2025 |
NCNO nCino | $23.95
+0.1% | 4/2/2025 | Target Lowered by | Needham & Company LLC | Analyst Mayank Tandon | Buy -> Buy | $45.00 -> $28.00 | High | View details for Needham & Company LLC rating of nCino (NASDAQ:NCNO) on 4/2/2025 |
MGNI Magnite | $11.13
+12.4% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $20.00 -> $20.00 | Medium | View details for Needham & Company LLC rating of Magnite (NASDAQ:MGNI) on 4/2/2025 |
CLBT Cellebrite DI | $18.90
-0.7% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Cikos | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of Cellebrite DI (NASDAQ:CLBT) on 4/2/2025 |
DSP Viant Technology | $12.80
+0.4% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $21.00 -> $21.00 | Medium | View details for Needham & Company LLC rating of Viant Technology (NASDAQ:DSP) on 4/2/2025 |
LPRO Open Lending | $0.83
-1.9% | 4/2/2025 | Target Lowered by | Needham & Company LLC | Analyst K. Peterson | Buy -> Buy | $7.00 -> $2.00 | High | View details for Needham & Company LLC rating of Open Lending (NASDAQ:LPRO) on 4/2/2025 |
PHAT Phathom Pharmaceuticals | $4.03
-4.5% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $28.00 -> $28.00 | High | View details for Needham & Company LLC rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 4/2/2025 |
AEYE AudioEye | $11.30
-2.1% | 4/2/2025 | Reiterated by | Needham & Company LLC | Analyst J. Reilly | Buy -> Buy | $25.00 -> $25.00 | High | View details for Needham & Company LLC rating of AudioEye (NASDAQ:AEYE) on 4/2/2025 |
ONON ON | $42.50
+1.8% | 4/1/2025 | Target Lowered by | Needham & Company LLC | Analyst T. Nikic | Buy -> Buy | $64.00 -> $50.00 | Medium | View details for Needham & Company LLC rating of ON (NYSE:ONON) on 4/1/2025 |
OMER Omeros | $6.78
+0.3% | 4/1/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Hold -> Hold | | High | View details for Needham & Company LLC rating of Omeros (NASDAQ:OMER) on 4/1/2025 |
AXSM Axsome Therapeutics | $104.46
0.0% | 4/1/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $153.00 -> $153.00 | Low | View details for Needham & Company LLC rating of Axsome Therapeutics (NASDAQ:AXSM) on 4/1/2025 |
PCVX Vaxcyte | $30.65
+5.3% | 4/1/2025 | Target Lowered by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $140.00 -> $90.00 | N/A | View details for Needham & Company LLC rating of Vaxcyte (NASDAQ:PCVX) on 4/1/2025 |
CELC Celcuity | $10.24
+2.5% | 4/1/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $29.00 -> $29.00 | High | View details for Needham & Company LLC rating of Celcuity (NASDAQ:CELC) on 4/1/2025 |
DV DoubleVerify | $12.47
+3.3% | 4/1/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $22.00 -> $22.00 | Low | View details for Needham & Company LLC rating of DoubleVerify (NYSE:DV) on 4/1/2025 |
CYRX Cryoport | $5.55
-1.1% | 3/31/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Buy | $11.00 -> $11.00 | High | View details for Needham & Company LLC rating of Cryoport (NASDAQ:CYRX) on 3/31/2025 |
TTGT TechTarget | $8.16
-2.9% | 3/31/2025 | Target Lowered by | Needham & Company LLC | Analyst Joshua Reilly | Buy -> Buy | $40.00 -> $25.00 | High | View details for Needham & Company LLC rating of TechTarget (NASDAQ:TTGT) on 3/31/2025 |
DDD 3D Systems | $1.86
-3.7% | 3/28/2025 | Reiterated by | Needham & Company LLC | Analyst James Ricchiuti | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of 3D Systems (NYSE:DDD) on 3/28/2025 |
BRZE Braze | $29.21
+2.8% | 3/28/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $50.00 -> $50.00 | High | View details for Needham & Company LLC rating of Braze (NASDAQ:BRZE) on 3/28/2025 |
CLSD Clearside Biomedical | $0.86
-1.1% | 3/28/2025 | Target Lowered by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $6.00 -> $4.00 | High | View details for Needham & Company LLC rating of Clearside Biomedical (NASDAQ:CLSD) on 3/28/2025 |
DFIN Donnelley Financial Solutions | $41.90
+3.0% | 3/28/2025 | Reiterated by | Needham & Company LLC | Analyst Kyle Peterson | Buy -> Buy | $72.00 -> $72.00 | High | View details for Needham & Company LLC rating of Donnelley Financial Solutions (NYSE:DFIN) on 3/28/2025 |
The Trump Dump is starting; Get out of stocks now? (Ad) The first 365 days of the Trump presidency…
Will be the best time to get rich in American history. If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a |
HOOD Robinhood Markets | $41.18
+1.3% | 3/28/2025 | Target Lowered by | Needham & Company LLC | Analyst J. Todaro | Buy -> Buy | $70.00 -> $62.00 | High | View details for Needham & Company LLC rating of Robinhood Markets (NASDAQ:HOOD) on 3/28/2025 |
ALC Alcon | $92.47
+0.5% | 3/28/2025 | Target Raised by | Needham & Company LLC | Analyst David Saxon | Buy -> Buy | $107.00 -> $110.00 | N/A | View details for Needham & Company LLC rating of Alcon (NYSE:ALC) on 3/28/2025 |
STTK Shattuck Labs | $0.77
+2.4% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst G. Blum | Hold -> Hold | | High | View details for Needham & Company LLC rating of Shattuck Labs (NASDAQ:STTK) on 3/27/2025 |
TBLA Taboola.com | $2.78
+1.1% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $4.00 -> $4.00 | High | View details for Needham & Company LLC rating of Taboola.com (NASDAQ:TBLA) on 3/27/2025 |
CTSH Cognizant Technology Solutions | $69.44
-0.8% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst Mayank Tandon | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 3/27/2025 |
CHWY Chewy | $35.18
+1.2% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst B. Mcternan | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Chewy (NYSE:CHWY) on 3/27/2025 |
ATRC AtriCure | $32.01
-0.2% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $51.00 -> $51.00 | High | View details for Needham & Company LLC rating of AtriCure (NASDAQ:ATRC) on 3/27/2025 |
NKTX Nkarta | $1.81
+3.4% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $11.00 -> $11.00 | High | View details for Needham & Company LLC rating of Nkarta (NASDAQ:NKTX) on 3/27/2025 |
CLBT Cellebrite DI | $18.90
-0.7% | 3/27/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Cikos | Buy -> Buy | $28.00 -> $28.00 | Medium | View details for Needham & Company LLC rating of Cellebrite DI (NASDAQ:CLBT) on 3/27/2025 |
VRNT Verint Systems | $15.99
+0.2% | 3/27/2025 | Target Lowered by | Needham & Company LLC | Analyst Joshua Reilly | Buy -> Buy | $40.00 -> $30.00 | High | View details for Needham & Company LLC rating of Verint Systems (NASDAQ:VRNT) on 3/27/2025 |
STZ Constellation Brands | $186.58
+1.9% | 3/27/2025 | Target Lowered by | Needham & Company LLC | Analyst G. Pascarelli | Buy -> Buy | $240.00 -> $215.00 | Low | View details for Needham & Company LLC rating of Constellation Brands (NYSE:STZ) on 3/27/2025 |
MREO Mereo BioPharma Group | $2.30
+8.0% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $7.00 -> $7.00 | High | View details for Needham & Company LLC rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/26/2025 |
KALV KalVista Pharmaceuticals | $12.00
+2.2% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $28.00 -> $28.00 | Low | View details for Needham & Company LLC rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 3/26/2025 |
MBLY Mobileye Global | $11.90
-3.3% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $20.00 -> $20.00 | High | View details for Needham & Company LLC rating of Mobileye Global (NASDAQ:MBLY) on 3/26/2025 |
TMDX TransMedics Group | $88.24
+3.3% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst M. Matson | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of TransMedics Group (NASDAQ:TMDX) on 3/26/2025 |
CLFD Clearfield | $26.51
+0.1% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan Koontz | Buy -> Buy | $50.00 -> $50.00 | Medium | View details for Needham & Company LLC rating of Clearfield (NASDAQ:CLFD) on 3/26/2025 |
SPSC SPS Commerce | $129.06
+0.3% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $210.00 -> $210.00 | Low | View details for Needham & Company LLC rating of SPS Commerce (NASDAQ:SPSC) on 3/26/2025 |
PATH UiPath | $10.44
+0.6% | 3/26/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Hold -> Hold | | Low | View details for Needham & Company LLC rating of UiPath (NYSE:PATH) on 3/26/2025 |
CRMD CorMedix | $7.67
+2.0% | 3/26/2025 | Target Lowered by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $18.00 -> $12.00 | High | View details for Needham & Company LLC rating of CorMedix (NASDAQ:CRMD) on 3/26/2025 |
LULU Lululemon Athletica | $251.08
+0.7% | 3/26/2025 | Target Lowered by | Needham & Company LLC | Analyst T. Nikic | Buy -> Buy | $475.00 -> $430.00 | Low | View details for Needham & Company LLC rating of Lululemon Athletica (NASDAQ:LULU) on 3/26/2025 |
ARTV Artiva Biotherapeutics | $2.24
-2.6% | 3/25/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Needham & Company LLC rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/25/2025 |
OCX OncoCyte | $2.84
+0.4% | 3/25/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $4.25 -> $4.25 | High | View details for Needham & Company LLC rating of OncoCyte (NASDAQ:OCX) on 3/25/2025 |
YOU Clear Secure | $26.74
+1.8% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Joshua Reilly | Buy -> Buy | $45.00 -> $45.00 | Low | View details for Needham & Company LLC rating of Clear Secure (NYSE:YOU) on 3/24/2025 |
LUCD Lucid Diagnostics | $1.21
+11.0% | 3/24/2025 | Target Raised by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $2.50 -> $3.00 | High | View details for Needham & Company LLC rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/24/2025 |
DNB Dun & Bradstreet | $8.75
+0.3% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Kyle Peterson | Buy -> Hold | $14.00 -> $14.00 | Low | View details for Needham & Company LLC rating of Dun & Bradstreet (NYSE:DNB) on 3/24/2025 |
ROKU Roku | $58.46
+0.1% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $120.00 -> $120.00 | Low | View details for Needham & Company LLC rating of Roku (NASDAQ:ROKU) on 3/24/2025 |
WDAY Workday | $221.02
-2.9% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $300.00 -> $300.00 | Medium | View details for Needham & Company LLC rating of Workday (NASDAQ:WDAY) on 3/24/2025 |
PL Planet Labs PBC | $3.23
+1.1% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan Koontz | Buy -> Buy | $8.00 -> $8.00 | Medium | View details for Needham & Company LLC rating of Planet Labs PBC (NYSE:PL) on 3/24/2025 |
ALIT Alight | $5.00
-0.7% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Kyle Peterson | Buy -> Buy | $9.00 -> $9.00 | Low | View details for Needham & Company LLC rating of Alight (NYSE:ALIT) on 3/24/2025 |
LYFT Lyft | $11.16
+3.0% | 3/24/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Lyft (NASDAQ:LYFT) on 3/24/2025 |
RDDT Reddit | $96.04
+0.7% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $220.00 -> $220.00 | High | View details for Needham & Company LLC rating of Reddit (NYSE:RDDT) on 3/21/2025 |
IMRX Immuneering | $1.27
+1.6% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $12.00 -> $12.00 | High | View details for Needham & Company LLC rating of Immuneering (NASDAQ:IMRX) on 3/21/2025 |
OB Outbrain | $3.30
+3.8% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $9.00 -> $9.00 | N/A | View details for Needham & Company LLC rating of Outbrain (NASDAQ:OB) on 3/21/2025 |
PRVA Privia Health Group | $23.68
-0.8% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst R. Macdonald | Buy -> Buy | $30.00 -> $30.00 | High | View details for Needham & Company LLC rating of Privia Health Group (NASDAQ:PRVA) on 3/21/2025 |
SYK Stryker | $346.46
-0.1% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $442.00 -> $442.00 | Medium | View details for Needham & Company LLC rating of Stryker (NYSE:SYK) on 3/21/2025 |
ATRC AtriCure | $32.01
-0.2% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $51.00 -> $51.00 | High | View details for Needham & Company LLC rating of AtriCure (NASDAQ:ATRC) on 3/21/2025 |
ALNY Alnylam Pharmaceuticals | $234.56
+1.8% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $320.00 -> $320.00 | High | View details for Needham & Company LLC rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 3/21/2025 |
TTMI TTM Technologies | $18.65
-0.2% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst James Ricchiuti | Buy -> Buy | $33.00 -> $33.00 | High | View details for Needham & Company LLC rating of TTM Technologies (NASDAQ:TTMI) on 3/21/2025 |
AGL agilon health | $4.02
-26.4% | 3/21/2025 | Reiterated by | Needham & Company LLC | Analyst M. Shea | Hold -> Hold | | High | View details for Needham & Company LLC rating of agilon health (NYSE:AGL) on 3/21/2025 |
NSSC Napco Security Technologies | $21.69
+0.4% | 3/21/2025 | Target Lowered by | Needham & Company LLC | Analyst James Ricchiuti | Buy -> Buy | $40.00 -> $37.00 | High | View details for Needham & Company LLC rating of Napco Security Technologies (NASDAQ:NSSC) on 3/21/2025 |
LQDA Liquidia | $13.72
+0.3% | 3/20/2025 | Target Raised by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $19.00 -> $25.00 | High | View details for Needham & Company LLC rating of Liquidia (NASDAQ:LQDA) on 3/20/2025 |
VERX Vertex | $39.25
+0.8% | 3/20/2025 | Reiterated by | Needham & Company LLC | Analyst Joshua Reilly | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Needham & Company LLC rating of Vertex (NASDAQ:VERX) on 3/20/2025 |
CYBR CyberArk Software | $325.84
-1.6% | 3/20/2025 | Reiterated by | Needham & Company LLC | Analyst M. Dezort | Buy -> Buy | $480.00 -> $480.00 | Low | View details for Needham & Company LLC rating of CyberArk Software (NASDAQ:CYBR) on 3/20/2025 |
ALC Alcon | $92.47
+0.5% | 3/20/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Buy | $107.00 -> $107.00 | N/A | View details for Needham & Company LLC rating of Alcon (NYSE:ALC) on 3/20/2025 |
SRAD Sportradar Group | $23.96
+0.4% | 3/20/2025 | Target Raised by | Needham & Company LLC | Analyst Bernie McTernan | Buy -> Buy | $18.00 -> $27.00 | Medium | View details for Needham & Company LLC rating of Sportradar Group (NASDAQ:SRAD) on 3/20/2025 |
SAH Sonic Automotive | $58.87
+1.1% | 3/19/2025 | Target Lowered by | Needham & Company LLC | Analyst Chris Pierce | Buy -> Buy | $100.00 -> $93.00 | Medium | View details for Needham & Company LLC rating of Sonic Automotive (NYSE:SAH) on 3/19/2025 |
ABSI Absci | $3.09
+1.3% | 3/19/2025 | Reiterated by | Needham & Company LLC | Analyst G. Blum | Buy -> Buy | $9.00 -> $9.00 | Medium | View details for Needham & Company LLC rating of Absci (NASDAQ:ABSI) on 3/19/2025 |
BTDR Bitdeer Technologies Group | $7.62
+3.3% | 3/19/2025 | Target Lowered by | Needham & Company LLC | Analyst John Todaro | Buy -> Buy | $18.00 -> $15.00 | High | View details for Needham & Company LLC rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/19/2025 |
TRVI Trevi Therapeutics | $6.07
-0.5% | 3/19/2025 | Target Lowered by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $25.00 -> $24.00 | High | View details for Needham & Company LLC rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/19/2025 |
NVDA NVIDIA | $101.33
-3.0% | 3/19/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $160.00 -> $160.00 | Low | View details for Needham & Company LLC rating of NVIDIA (NASDAQ:NVDA) on 3/19/2025 |
The Trump Dump is starting; Get out of stocks now? (Ad) The first 365 days of the Trump presidency…
Will be the best time to get rich in American history. If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a |
SRPT Sarepta Therapeutics | $53.79
-0.3% | 3/18/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $202.00 -> $202.00 | High | View details for Needham & Company LLC rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/18/2025 |
STOK Stoke Therapeutics | $7.69
+1.7% | 3/18/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $22.00 -> $22.00 | High | View details for Needham & Company LLC rating of Stoke Therapeutics (NASDAQ:STOK) on 3/18/2025 |
HAE Haemonetics | $57.10
+0.4% | 3/18/2025 | Target Lowered by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $108.00 -> $104.00 | Low | View details for Needham & Company LLC rating of Haemonetics (NYSE:HAE) on 3/18/2025 |
RYTM Rhythm Pharmaceuticals | $61.74
+0.7% | 3/18/2025 | Target Raised by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $64.00 -> $66.00 | High | View details for Needham & Company LLC rating of Rhythm Pharmaceuticals (NASDAQ:RYTM) on 3/18/2025 |
GMED Globus Medical | $71.03
-0.2% | 3/18/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Globus Medical (NYSE:GMED) on 3/18/2025 |
CRNC Cerence | $7.59
+3.4% | 3/18/2025 | Reiterated by | Needham & Company LLC | Analyst N. Bolton | Buy -> Buy | $16.00 -> $16.00 | N/A | View details for Needham & Company LLC rating of Cerence (NASDAQ:CRNC) on 3/18/2025 |
RNA Avidity Biosciences | $26.66
+3.5% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $60.00 -> $60.00 | High | View details for Needham & Company LLC rating of Avidity Biosciences (NASDAQ:RNA) on 3/17/2025 |
LIVN LivaNova | $35.58
+1.5% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Buy -> Buy | $64.00 -> $64.00 | High | View details for Needham & Company LLC rating of LivaNova (NASDAQ:LIVN) on 3/17/2025 |
APP AppLovin | $238.22
+3.7% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of AppLovin (NASDAQ:APP) on 3/17/2025 |
NKE NIKE | $55.73
+4.1% | 3/17/2025 | Target Lowered by | Needham & Company LLC | Analyst T. Nikic | Buy -> Buy | $84.00 -> $80.00 | High | View details for Needham & Company LLC rating of NIKE (NYSE:NKE) on 3/17/2025 |
FRSH Freshworks | $12.60
+0.5% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $25.00 -> $25.00 | Low | View details for Needham & Company LLC rating of Freshworks (NASDAQ:FRSH) on 3/17/2025 |
BILL BILL | $40.63
-0.7% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $100.00 -> $100.00 | Low | View details for Needham & Company LLC rating of BILL (NYSE:BILL) on 3/17/2025 |
FIVN Five9 | $22.32
-1.3% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $52.00 -> $52.00 | Medium | View details for Needham & Company LLC rating of Five9 (NASDAQ:FIVN) on 3/17/2025 |
FN Fabrinet | $183.63
-1.6% | 3/17/2025 | Reiterated by | Needham & Company LLC | Analyst R. Koontz | Buy -> Buy | $280.00 -> $280.00 | Medium | View details for Needham & Company LLC rating of Fabrinet (NYSE:FN) on 3/17/2025 |
COMP Compass | $7.30
-3.9% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Buy -> Buy | $12.00 -> $12.00 | Low | View details for Needham & Company LLC rating of Compass (NYSE:COMP) on 3/14/2025 |
NABL N-able | $6.33
-1.8% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Cikos | Buy -> Buy | $10.00 -> $10.00 | Low | View details for Needham & Company LLC rating of N-able (NYSE:NABL) on 3/14/2025 |
KLTR Kaltura | $1.97
-2.0% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan Koontz | Buy -> Buy | $3.00 -> $3.00 | High | View details for Needham & Company LLC rating of Kaltura (NASDAQ:KLTR) on 3/14/2025 |
GBIO Generation Bio | $0.39
+12.4% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $8.00 -> $8.00 | High | View details for Needham & Company LLC rating of Generation Bio (NASDAQ:GBIO) on 3/14/2025 |
BLNK Blink Charging | $0.68
+0.2% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst C. Pierce | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of Blink Charging (NASDAQ:BLNK) on 3/14/2025 |
SMTC Semtech | $26.22
+0.9% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $54.00 -> $54.00 | High | View details for Needham & Company LLC rating of Semtech (NASDAQ:SMTC) on 3/14/2025 |
QBTS D-Wave Quantum | $6.39
-0.9% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $8.50 -> $8.50 | High | View details for Needham & Company LLC rating of D-Wave Quantum (NYSE:QBTS) on 3/14/2025 |
TTAN ServiceTitan | $119.89
+1.9% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst S. Berg | Buy -> Buy | $125.00 -> $125.00 | High | View details for Needham & Company LLC rating of ServiceTitan (NASDAQ:TTAN) on 3/14/2025 |
DOCU DocuSign | $75.42
-1.3% | 3/14/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Hold -> Hold | | High | View details for Needham & Company LLC rating of DocuSign (NASDAQ:DOCU) on 3/14/2025 |
RNAC Cartesian Therapeutics | $10.50
-0.7% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $41.00 -> $41.00 | Medium | View details for Needham & Company LLC rating of Cartesian Therapeutics (NASDAQ:RNAC) on 3/13/2025 |
IRBT iRobot | $2.01
| 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst James Ricchiuti | Hold -> Hold | | High | View details for Needham & Company LLC rating of iRobot (NASDAQ:IRBT) on 3/13/2025 |
KALV KalVista Pharmaceuticals | $12.00
+2.2% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Serge Belanger | Buy -> Buy | $28.00 -> $28.00 | Medium | View details for Needham & Company LLC rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 3/13/2025 |
S SentinelOne | $16.82
-1.6% | 3/13/2025 | Target Lowered by | Needham & Company LLC | Analyst Matt Dezort | Buy -> Buy | $32.00 -> $23.00 | High | View details for Needham & Company LLC rating of SentinelOne (NYSE:S) on 3/13/2025 |
NET Cloudflare | $107.81
-1.6% | 3/13/2025 | Target Lowered by | Needham & Company LLC | Analyst Mike Cikos | Buy -> Buy | $185.00 -> $145.00 | Medium | View details for Needham & Company LLC rating of Cloudflare (NYSE:NET) on 3/13/2025 |
AEYE AudioEye | $11.30
-2.1% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst J. Reilly | Buy -> Buy | $25.00 -> $25.00 | High | View details for Needham & Company LLC rating of AudioEye (NASDAQ:AEYE) on 3/13/2025 |
TNET TriNet Group | $75.95
-3.2% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst K. Peterson | Hold -> Hold | | Low | View details for Needham & Company LLC rating of TriNet Group (NYSE:TNET) on 3/13/2025 |
PHR Phreesia | $23.92
+0.1% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan MacDonald | Buy -> Buy | $29.00 -> $29.00 | High | View details for Needham & Company LLC rating of Phreesia (NYSE:PHR) on 3/13/2025 |
CDLX Cardlytics | $1.50
| 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Kyle Peterson | Hold -> Hold | | High | View details for Needham & Company LLC rating of Cardlytics (NASDAQ:CDLX) on 3/13/2025 |
MX Magnachip Semiconductor | $2.92
+0.5% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $6.00 -> $6.00 | Low | View details for Needham & Company LLC rating of Magnachip Semiconductor (NYSE:MX) on 3/13/2025 |
UPLD Upland Software | $2.19
-2.7% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Hold -> Hold | | Low | View details for Needham & Company LLC rating of Upland Software (NASDAQ:UPLD) on 3/13/2025 |
PATH UiPath | $10.44
+0.6% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Hold -> Hold | | High | View details for Needham & Company LLC rating of UiPath (NYSE:PATH) on 3/13/2025 |
TTD Trade Desk | $50.26
+3.7% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $145.00 -> $145.00 | High | View details for Needham & Company LLC rating of Trade Desk (NASDAQ:TTD) on 3/13/2025 |
ZIMV ZimVie | $9.39
+1.5% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Hold | | Medium | View details for Needham & Company LLC rating of ZimVie (NASDAQ:ZIMV) on 3/13/2025 |
XRAY DENTSPLY SIRONA | $12.83
+1.4% | 3/13/2025 | Reiterated by | Needham & Company LLC | Analyst David Saxon | Buy -> Hold | | Medium | View details for Needham & Company LLC rating of DENTSPLY SIRONA (NASDAQ:XRAY) on 3/13/2025 |
UDMY Udemy | $6.14
+0.4% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Ryan MacDonald | Buy -> Buy | $11.00 -> $11.00 | High | View details for Needham & Company LLC rating of Udemy (NASDAQ:UDMY) on 3/12/2025 |
CURI CuriosityStream | $3.17
+8.9% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Laura Martin | Buy -> Buy | $3.00 -> $3.00 | High | View details for Needham & Company LLC rating of CuriosityStream (NASDAQ:CURI) on 3/12/2025 |
ACVA ACV Auctions | $14.28
+1.3% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Chris Pierce | Buy -> Buy | $25.00 -> $25.00 | High | View details for Needham & Company LLC rating of ACV Auctions (NASDAQ:ACVA) on 3/12/2025 |
BIGC BigCommerce | $5.09
| 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Needham & Company LLC rating of BigCommerce (NASDAQ:BIGC) on 3/12/2025 |
GLBE Global-E Online | $32.44
+1.4% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Scott Berg | Buy -> Buy | $64.00 -> $64.00 | Medium | View details for Needham & Company LLC rating of Global-E Online (NASDAQ:GLBE) on 3/12/2025 |
TFX Teleflex | $129.57
+1.1% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Mike Matson | Hold -> Hold | | Medium | View details for Needham & Company LLC rating of Teleflex (NYSE:TFX) on 3/12/2025 |
GLOB Globant | $105.69
-0.8% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Mayank Tandon | Buy -> Buy | $220.00 -> $220.00 | High | View details for Needham & Company LLC rating of Globant (NYSE:GLOB) on 3/12/2025 |
IMCR Immunocore | $28.41
+1.9% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $71.00 -> $71.00 | Low | View details for Needham & Company LLC rating of Immunocore (NASDAQ:IMCR) on 3/12/2025 |
CIEN Ciena | $60.22
+2.3% | 3/12/2025 | Target Lowered by | Needham & Company LLC | Analyst Ryan Koontz | Buy -> Buy | $95.00 -> $90.00 | Medium | View details for Needham & Company LLC rating of Ciena (NYSE:CIEN) on 3/12/2025 |
GERN Geron | $1.27
+2.4% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Gil Blum | Buy -> Buy | $5.00 -> $5.00 | High | View details for Needham & Company LLC rating of Geron (NASDAQ:GERN) on 3/12/2025 |
TLS Telos | $2.50
-0.8% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Matt Dezort | Hold -> Hold | | High | View details for Needham & Company LLC rating of Telos (NASDAQ:TLS) on 3/12/2025 |
VRCA Verrica Pharmaceuticals | $0.49
+2.4% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst S. Belanger | Hold -> Hold | | High | View details for Needham & Company LLC rating of Verrica Pharmaceuticals (NASDAQ:VRCA) on 3/12/2025 |
SLAB Silicon Laboratories | $90.50
+0.6% | 3/12/2025 | Reiterated by | Needham & Company LLC | Analyst Quinn Bolton | Buy -> Buy | $150.00 -> $150.00 | High | View details for Needham & Company LLC rating of Silicon Laboratories (NASDAQ:SLAB) on 3/12/2025 |
WNS WNS | $66.54
-0.1% | 3/11/2025 | Target Raised by | Needham & Company LLC | Analyst Mayank Tandon | Buy -> Buy | $65.00 -> $70.00 | Low | View details for Needham & Company LLC rating of WNS (NYSE:WNS) on 3/11/2025 |
BCYC Bicycle Therapeutics | $7.39
-1.3% | 3/11/2025 | Reiterated by | Needham & Company LLC | Analyst Ami Fadia | Buy -> Buy | $30.00 -> $30.00 | High | View details for Needham & Company LLC rating of Bicycle Therapeutics (NASDAQ:BCYC) on 3/11/2025 |
RDFN Redfin | $8.44
-1.5% | 3/11/2025 | Reiterated by | Needham & Company LLC | Analyst Bernie McTernan | Hold -> Hold | | High | View details for Needham & Company LLC rating of Redfin (NASDAQ:RDFN) on 3/11/2025 |
AMPL Amplitude | $8.18
-1.4% | 3/11/2025 | Reiterated by | Needham & Company LLC | Analyst S. Berg | Buy -> Buy | $16.00 -> $16.00 | Medium | View details for Needham & Company LLC rating of Amplitude (NASDAQ:AMPL) on 3/11/2025 |
INZY Inozyme Pharma | $0.92
-4.4% | 3/11/2025 | Target Lowered by | Needham & Company LLC | Analyst Joseph Stringer | Buy -> Buy | $23.00 -> $15.00 | High | View details for Needham & Company LLC rating of Inozyme Pharma (NASDAQ:INZY) on 3/11/2025 |
OCUL Ocular Therapeutix | $7.31
+2.0% | 3/11/2025 | Initiated by | Needham & Company LLC | Analyst Serge Belanger | Buy | $15.00 | High | View details for Needham & Company LLC rating of Ocular Therapeutix (NASDAQ:OCUL) on 3/11/2025 |
BLZE Backblaze | $4.69
| 3/11/2025 | Initiated by | Needham & Company LLC | Analyst Matt Dezort | Buy | $8.00 | Medium | View details for Needham & Company LLC rating of Backblaze (NASDAQ:BLZE) on 3/11/2025 |
DASH DoorDash | $181.24
+1.0% | 3/3/2025 | Reiterated by | Needham & Company LLC | - | Buy -> Buy | | High | View details for Needham & Company LLC rating of DoorDash (NASDAQ:DASH) on 3/3/2025 |
GENI Genius Sports | $10.35
+1.2% | 3/5/2025 | Target Set by | Needham & Company LLC | - | | $13.00 | N/A | View details for Needham & Company LLC rating of Genius Sports (NYSE:GENI) on 3/5/2025 |
